March 30, 2020
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals Provides Updates on Leadership Transition and Business Operations
March 30, 2020
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities
March 30, 2020
MyoKardia
MyoKardia Announces Mavacamten Treatment Well Tolerated and Significantly Reduced Biomarkers of Cardiac Injury and Wall Stress in Non-Obstructive Hypertrophic Cardiomyopathy Patients
March 30, 2020
CytomX Therapeutics
CytomX Therapeutics Announces Milestone Achievement in AbbVie CD71 Partnership and Provides Update on Impact of COVID-19 on Clinical Stage Pipeline
March 30, 2020
Agios Pharmaceuticals
Agios Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Mitapivat in Pyruvate Kinase Deficiencyag